Hyalgan Sodium Hyaluronate Injection from Japan
Hyalgan is a sterile, nonpyrogenic solution of sodium hyaluronate used for intra-articular injection to relieve knee pain due to osteoarthritis. It contains hyaluronic acid sodium salt in measured doses, qualifying under HTS 3004.90.10.00 as a medicament for therapeutic use put up in forms for retail sale.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Verify FDA approval and provide Certificate of Pharmaceutical Product (CPP) for customs clearance
• Ensure cold chain documentation to maintain sterility during transit
• Label accurately with exact hyaluronic acid concentration to avoid reclassification